Circulating levels of IL-11 and leukaemia inhibitory factor (LIF) do not significantly participate in the production of acute-phase proteins by the liver

Clinical and Experimental Immunology

Volumn 105, Issue 2, 1996, Pages 260-266

  Gabay, C ^a   Singwe, M ^a   Genin, B ^a   Meyer, O ^b   Mentha, G ^a   Le Coultre, C ^a   Vischer, T ^a   Guerne, P A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b BICHAT HOSPITAL   (France)

Author keywords

Acute phase proteins; Hepatocytes; Human primary; IL 11; IL 6; Leukaemia inhibitory factor

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030037650     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-757.x     Document Type: Article

References (42)

1. Gauldie J, Richards C, Harnish D, Lansdorf P, Baumann H. Interferon β2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987; 84:7251-5.
2. Castell JV, Gomez-Lechon MJ, David M, Andus T, Geiger T, Trullenque R, Fabra R, Heinrich PC. lnterleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Letters 1989; 242:237-9.
3. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute-phase response. Biochem J 1990; 265:621-36.
4. Baumann H, Schendel P. Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem 1991; 30:20424-7.
5. Baumann H, Wong GG. Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol 1989; 143:1163-7.
6. Hilton DJ, Gough NM. Leukemia inhibitory factor: a biological perspective. J Cell Biochem 1991; 46:21 26.
7. Burnstein SA, Mei R-L, Henthorn J, Friese P, Turner K. Leukemia inhibitory factor and interleukin-11 promote maturation of murine and human magakaryocytes in vitro. J Cell Physiol 1992; 153:305-12.
8. Maier R, Ganu V, Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of inetalloproteinases. J Biol Chem 1993: 268:21527-32.
9. Gabay C, Genin B, Mentha G, Iynedjian PB, Roux-Lombard P, Guerne P-A. IL-1 receptor antagonist (IL-1Ra) does not inhibit the production of C-reactive protein or serum amyloid A protein by human primary hepatocytes. Differential regulation in normal and tumour cells. Clin Exp Immunol 1995; 100:306-13.
10. Gabay C, Silacci P, Genin B, Mentha G, Le Coultre C, Guerne P-A. Soluble interleukin-6 receptor strongly increases the production of acute-phase protein by hepatoma cells but exerts minimal changes on human primary hepatocytes. Eur J Immunol 1995; 25:2378-83.
11. Waring P, Wycherley K, Cary D, Nicola N, Metcalf D. Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids. J Clin Invest 1992; 90:2031-7.
12. Lecron JC, Roblot P, Chevalier S, Morel F, Alderman E, Gombert J, Gascan H. High circulating leukaemia inhibitory factor (LIF) in patients with giant cell arteritis: independent regulation of LIF and IL-6 under corticosteroid therapy. Clin Exp Immunol 1993; 92:23-26.
13. Honig S, Gorevic P, Weissmann G. C-reactive protein in systemic lupus erythematosus. Arthritis Rheum 1977; 20:1065-70.
14. Pepys MB, Lanham JG, De Beer FC. C-reactive protein in SLE. Clin Rheum Dis 1982; 8:91-101.
15. Gabay C, Roux-Lombard P, De Moerloose Ph, Dayer J-M. Vischer T, Guerne P-A. Absence of correlation between interleukin-6 and C-reactive protein blood levels in systemic lupus erythematosus compared with rheumatoid arthritis. J Rheumatol 1993; 20:815-21.
16. Metsärinne KP, Nordström DCE, Kontinnen YT, Teppo A-M, Fyhrquist FY. Plasma interleukin-6 and renin substrate in reactive arthritis, rheumatoid arthritis, and systemic lupus erythematosus. Rheumatol Int 1992; 12:93-96.
17. Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozcri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol 1991; 147:117-23.
18. Spronk PE, ter Borg EJ, Limburg PC, Kallenberg CGM. Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity. Clin Exp Immunol 1992; 90:106-10.
19. Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S. Cytokine profile in systemic lupus erythematosus. rheumatoid arthritis, and other rheumatic diseases. J Clin Immunol 1993; 13:58-67.
20. Gabay C, Gay-Crosier F, Roux-Lombard P, Meyer O, Guerne P-A, Vischer T, Dayer J-M. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis-dermatomyositis: a biological marker of disease activity with a possible role in the lack of acute-phase protein response. Arthritis Rheum 1994; 37:1744-51.
21. Guerne P-A, Cekir N, Moral F, Roux-Lombard P, Gabay C, Yazici H, Dayer J-M, Vischer T. Levels of TNF soluble receptors are markedly elevated in systemic lupus erythematosus in contrast to rheumatoid arthritis. Highly significant correlation with disease activity. Arthritis Rheum 1993; 36 (Suppl.):S147 (Abstr.).
22. Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol 1976; 13:29-83.
23. Loyer P, Ilyin G, Razzak ZA, Banchereau J, Dezier J-F, Campion J-P, Guguen-Guillouzo C, Guillouzo A. Interleukin 4 inhibits the production of some acute-phase proteins by human hepatocytes in primary culture. FEBS Letters 1993; 336:215-20.
24. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271-7.
25. Liang MH, Socher SA, Larson MG. Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in the systemic lupus erythematosus. Arthritis Rheum 1989; 32:1107-18.
26. Arnett FC, Edworthy SM. Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987; 31:315-24.
27. Dougados M, Van der Linden S, Juhlin R et al. The European spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34:1218-27.
28. Baumann H, Gauldie J. Regulation of hepatic acute phase plasma protein genes by hepatocyte stimulating factors and other mediators of inflammation. Mol Biol Med 1990; 7:147-60.
29. Ganapathi MK, Rzewnicki D, Samols D, Jiang S-L, Kushner I. Effect of combinations of cytokines and hormones on synthesis of serum A amyloid and C-reactive protein in Hep 3B cells. J Immunol 1991; 147:1261 5.
30. Waring PM, Caroll GJ, Kandiah DA, Buirski G, Metcalf D. Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1993; 36:911-5.
31. Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M. Synovium as a source of interleukin-6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 1989; 83:585.
32. Guerne P-A, Carson DA, Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 1990; 144:499-505.
33. Lotz M, Moats T, Villiger PM. Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the palhogenesis of arthritis. J Clin Invest 1992; 90:888-96.
34. Zhang X-G, Gu J-J, Lu Z-Y et al. Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer GP130. J Exp Med 1994; 177:1337-42.
35. Stahl N, Yancopoulos GD, The alphas, betas, and kinases of cytokine receptor complexes. Cell 1993; 74:587-90.
36. Yin T, Taga T, Lik-Shing Tsang M, Yasukawa K, Kishimoto T, Yang Y-C. Involvement of IL-6 signal transducer gp130 in IL-11-mediated signal transduction. J Immunol 1993; 151:2555-61.
37. Nishimoto N, Ogata A, Shima Y et al. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmocytoma cells via the common signal transducer, GP130. J Exp Med 1994; 179:1343-7.
38. Piquet-Pellorce C, Mereau GA, Heath JK. Are LIF and related cytokines functionally equivalent? Exp Cell Research 1994; 213:340-7.
39. Gordon MS, Sledge Jr GW, Battiato L el at. The in rivo effects or subcutaneously (sc) administered recombinant human interleukin-11 (NeumegaG rhIL-11 growth factor; rhIL-11) in women with breast cancer (BC). Blood 1993; 82 (Suppl. 1):498a (Abstr.).
40. Girasole G, Passen G, Jilka RL, Manolagas SC. Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 1994; 93:1516-24.
41. Barton BE, Jackson JV, Lee F, Wagner J. Oncostatin M stimulates proliferation in B9 hybridoma cells: potential role of oncostatin M in plasmocytoma development. Cytokine 1994; 6:147-53.
42. Schooltink H, Stoyan T, Roeb E, Heinrich PC, Rose-John S. Ciliary neurotrophic factor induces acute-phase protein expression in hepatocytes. FEBS Letters 1992; 314:280-4.